* AxoGen Inc AXGN.OQ reported a quarterly adjusted loss
of 3
cents per share for the quarter ended in June. The mean
expectation of five analysts for the quarter was for a loss
of 13 cents per share.
* Revenue rose 10.7% to $38.16 million from a year ago;
analysts
expected $39.08 million.
* AxoGen Inc's reported EPS for the quarter was a loss of 16
cents.
* The mean earnings estimate of analysts had risen by
about 3.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* AxoGen Inc shares had fallen by 7.8% this quarter and
lost 15.6%
so far this year.
* The company reported a quarterly loss of $6.66 million.
* Wall Street's median 12-month price target for AxoGen Inc
is
$17.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
August 7 at 09:00 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.13 -0.03 Beat
Mar. 31 2023 -0.14 -0.10 Beat
Dec. 31 2022 -0.11 -0.03 Beat
Sep. 30 2022 -0.12 -0.01 Beat